Ray Dalio Bristol Myers Squibb CO Transaction History
Bridgewater Associates, LP
- $19.6 Billion
- Q1 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bridgewater Associates, LP holds 703,226 shares of BMY stock, worth $28.9 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
703,226
Previous 705,207
0.28%
Holding current value
$28.9 Million
Previous $36.2 Million
5.39%
% of portfolio
0.19%
Previous 0.2%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,552Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.65 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.68 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.76 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.65 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.88 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $87.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...